Jul 31, 2026 05:13AM
Jul 16, 2026 07:30AM
May 21, 2026 09:17AM
May 21, 2026 09:00AM
May 21, 2026 06:37AM
May 21, 2026 06:20AM
May 20, 2026 07:08AM Roivant Sciences Ltd. (ROIV) Tops Q4 EPS by 57c
Mar 30, 2026 09:21AM
Mar 20, 2026 08:38AM
Mar 20, 2026 08:38AM
Mar 4, 2026 08:36AM
Mar 4, 2026 06:42AM
Mar 3, 2026 05:30PM
Mar 3, 2026 04:33PM After-hours movers: Moderna, CrowdStrike, Ross Stores, Box and more
Mar 3, 2026 04:16PM
Mar 3, 2026 10:51AM
Feb 10, 2026 06:52AM
Feb 10, 2026 06:31AM
Feb 10, 2026 06:13AM
Feb 9, 2026 05:57AM
Feb 6, 2026 07:48AM Roivant Sciences Ltd. (ROIV) Misses Q3 EPS by 7c
Jan 6, 2026 07:37AM
Dec 15, 2025 06:40AM
Dec 15, 2025 06:19AM
Dec 12, 2025 06:07AM
Dec 11, 2025 07:32AM
Nov 14, 2025 04:59AM
Nov 11, 2025 04:49AM Roivant Sciences (ROIV) PT Raised to $29 at Leerink Partners
Nov 10, 2025 03:58PM
Nov 10, 2025 08:04AM
Oct 30, 2025 02:47PM
Oct 3, 2025 04:35PM
Oct 1, 2025 01:20PM
Oct 1, 2025 01:13PM
Sep 30, 2025 02:17AM Goldman Sachs Reiterates Buy Rating on Roivant Sciences (ROIV)
Sep 18, 2025 06:59AM
Sep 17, 2025 04:44PM
Sep 17, 2025 04:10PM
Sep 17, 2025 03:36PM
Sep 17, 2025 12:33PM
Sep 10, 2025 01:44PM
Sep 4, 2025 07:02AM Pulmovant receives orphan drug status in Japan for lung disease treatment
Sep 2, 2025 09:28AM
Aug 12, 2025 06:27AM
Aug 11, 2025 07:08AM
Jul 25, 2025 07:46AM
Jul 21, 2025 05:21AM
Jul 10, 2025 06:26AM
Jun 25, 2025 08:50AM Roivant Sciences authorizes $500 million share repurchase program
Jun 18, 2025 07:10AM

439,043 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All